The route to commercialisation for biotechs is never an easy one. How many would wish IPD could become the next Cochlear or Resmed but the truth is, these sucess stories are too rare. Saying that, I believe IPD could have a very good chance at that. Beyond lympodemia, the technology has many avenues it can pursue like weight loss (measuring muscle mass and fat). We'll just have to wait and see I guess.
- Forums
- ASX - By Stock
- Morgans
The route to commercialisation for biotechs is never an easy...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $117.3M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.7¢ | $24.84K | 428.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 162253 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 586841 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 162253 | 0.058 |
2 | 260016 | 0.057 |
4 | 698381 | 0.055 |
2 | 551851 | 0.054 |
2 | 260000 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 586841 | 3 |
0.060 | 243829 | 3 |
0.062 | 250008 | 1 |
0.063 | 100000 | 1 |
0.064 | 450000 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |